rolipram has been researched along with Angiogenesis, Pathologic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rolipram was effective in inhibiting angiogenesis as assessed by hemoglobin content and VEGF levels in subcutaneous implants (about 40% with both doses) but failed to exert this activity in intraperitoneal implants." | 1.35 | Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. ( Andrade, SP; Araújo, FA; Ferreira, MA; Mendes, JB; Moura, SA; Rocha, MA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramezani, S | 1 |
| Vousooghi, N | 1 |
| Ramezani Kapourchali, F | 1 |
| Yousefzadeh-Chabok, S | 1 |
| Reihanian, Z | 1 |
| Alizadeh, AM | 1 |
| Khodayari, S | 1 |
| Khodayari, H | 1 |
| Mendes, JB | 1 |
| Rocha, MA | 1 |
| Araújo, FA | 1 |
| Moura, SA | 1 |
| Ferreira, MA | 1 |
| Andrade, SP | 1 |
2 other studies available for rolipram and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevaciz | 2019 |
Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice.
Topics: Administration, Oral; Animals; Chemokine CCL2; Collagen; Disease Models, Animal; Fibrosis; Inflammat | 2009 |